Last Updated: October 2023

Minnesota Green Check Verified


Medical Cannabis Therapeutic Research Act (2014)


Current law limits the medical cannabis program to two (2) medical cannabis manufacturers. The Minnesota Department of Health has registered two medical cannabis manufacturers: Vireo Health of Minnesota (Green Goods) and Leafline Labs (RISE). Minnesota law does not allow registration of additional medical cannabis manufacturers.

Medical Cannabis Patient Center Locations can be viewed here.

Adult Use Dispensaries Expected to Open in February of 2025

Proposed Rules for Adult Use

MN Cannabis Program

MN Proposed Rules


Regulatory Agencies

Minnesota Department of Health – Medical Cannabis

Tribal Nations

  • Medical Marijuana

The following tribes have voted to legalize production, regulation and distribution of medical marijuana on their reservations:

  • Red Lake Nation – In May 2020 the Red Lake Nation became the first tribe in Minnesota to approve medical marijuana.
  • White Earth Nation – In August 2020 the White Earth Nation voted 994-150 to legalize medical marijuana.

Program Dashboard (most current stats)

THC Beverages and Edibles

HF 4056

  • (c) “Edible cannabinoid product” means any product that is intended to be eaten or consumed as a beverage by humans, contains a cannabinoid in combination with food ingredients, and is not a drug.
  • Subd. 3. Sale of cannabinoids derived from hemp.
    • (a) Notwithstanding any other section of this chapter, a product containing nonintoxicating cannabinoids, including an edible cannabinoid product, may be sold for human or animal consumption only if all of the requirements of this section are met, provided that a product sold for human or animal consumption does not contain more than 0.3 percent of any tetrahydrocannabinol and an edible cannabinoid product does not contain an amount of any tetrahydrocannabinol that exceeds the limits established in subdivision 5a, paragraph (f).
    • […]
    • (c) No product containing any cannabinoid or tetrahydrocannabinol extracted or otherwise derived from hemp may be sold to any individual who is under the age of 21.
  • (f) An edible cannabinoid product must not contain more than five milligrams of any tetrahydrocannabinol in a single serving, or more than a total of 50 milligrams of any tetrahydrocannabinol per package

152.37 Financial Examinations; Pricing Reviews:

Financial records. A medical cannabis manufacturer shall maintain detailed financial records in a manner and format approved by the commissioner, and shall keep all records updated and accessible to the commissioner when requested.

Certified annual audit. A medical cannabis manufacturer shall submit the results of an annual certified financial audit to the commissioner no later than May 1 of each year for the calendar year beginning January 2015. The annual audit shall be conducted by an independent certified public accountant and the costs of the audit are the responsibility of the medical cannabis manufacturer. Results of the audit shall be provided to the medical cannabis manufacturer and the commissioner. The commissioner may also require another audit of the medical cannabis manufacturer by a certified public accountant chosen by the commissioner with the costs of the audit paid by the medical cannabis manufacturer.

Power to examine:

(a) The commissioner or designee may examine the business affairs and conditions of any medical cannabis manufacturer, including but not limited to a review of the financing, budgets, revenues, sales, and pricing.

(b) An examination may cover the medical cannabis manufacturer’s business affairs, practices, and conditions including but not limited to a review of the financing, budgets, revenues, sales, and pricing. The commissioner shall determine the nature and scope of each examination and in doing so shall take into account all available relevant factors concerning the financial and business affairs, practices, and conditions of the examinee. The costs incurred by the department in conducting an examination shall be paid for by the medical cannabis manufacturer.

(c) When making an examination under this section, the commissioner may retain attorneys, appraisers, independent economists, independent certified public accountants, or other professionals and specialists as designees. A certified public accountant retained by the commissioner may not be the same certified public accountant providing the certified annual audit in subdivision 2.

(d) The commissioner shall make a report of an examination conducted under this section and provide a copy to the medical cannabis manufacturer. The commissioner shall then post a copy of the report on the department’s website. All working papers, recorded information, documents, and copies produced by, obtained by, or disclosed to the commissioner or any other person in the course of an examination, other than the information contained in any commissioner official report, made under this section are private data on individuals or nonpublic data, as defined in section 13.02.

Click here for Medical Cannabis and Data Reports and Program Demographics.

A pharmacist determines the recommended daily dosage and calculates an amount equal to a 30-day supply at maximum recommended dosage. Medical dosages are limited to:

  • Liquids, oils, pills and topicals.

A registered patient, designated caregiver, or the registered patient’s parent or legal guardian, if the parent or legal guardian will be acting as a caregiver, must present a government-issued photo identification at the distribution site. Distribution site staff must verify the identity of the person and the patient’s enrollment in the registry.

A registered qualifying patient, registered designated caregiver, or a patient’s registered parent or registered legal guardian may purchase medical cannabis in quantities less than or equal to the patient’s 30-day supply determined under subpart 3 from any Minnesota distribution site at any time. The total quantity of medical cannabis purchased for a patient in a 23-day period must not exceed the patient’s 30-day supply.

Minors under the age of 18 must also register with the Minnesota Department of Health and have a designated caregiver.

Minnesota does not recognize out-of-state medical marijuana card holders.

Minnesota’s Medical Cannabis Program will add edibles in the form of gummies and chews with the option for delivery by no later than August 2022. Additionally, patients and caregivers will be eligible to purchase dried raw (smokable) cannabis in March 2022.

State Cannabis Regulatory Authority

Minnesota Adult Use Cannabis Program General Inquiries

Or via phone @ 651-201-5598  (toll free) 844-879-3381 

Cannabis – Medical

Mailing Address:

Office of Medical Cannabis
PO Box 64882
St. Paul, MN 55164-0882


Subscribe for Cannabis Updates:

Dashboard: Minnesota Medical Cannabis Dashboard – Minnesota Department of Health (

651-201-5598 844-879-3381 (toll-free)

Questions can also be emailed to:

State Banking Regulatory Authority

Minnesota Commerce Department

Minnesota Department of Commerce
85 7th Place East, Suite 280
Saint Paul, MN 55101

651-539-1500 800-657-3602


Credit Union:

Subscribe for e-mail updates: (Bottom of the page)